Cargando…
STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression
INTRODUCTION: This study was designed to investigate the roles of STAT3 and SMYD3 in chronic lymphocytic leukemia and the regulatory relationship between STAT3 and SMYD3 in chronic lymphocytic leukemia. MATERIAL AND METHODS: The expression of STAT3 and SMYD3 was determined by RT-qPCR and western blo...
Autores principales: | Ma, Wei, Zhang, Yingying, Qi, Yu, Guo, Shidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764298/ https://www.ncbi.nlm.nih.gov/pubmed/31572461 http://dx.doi.org/10.5114/aoms.2018.77733 |
Ejemplares similares
-
Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020) -
SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021) -
Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021) -
SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis
por: Yue, Fu-Ren, et al.
Publicado: (2020) -
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
por: Su, Haibi, et al.
Publicado: (2022)